Reply to: On the questionable ethics of randomizing patients with acute DVT to receive rivaroxaban or warfarin

Affiliations

¹ Hospital do Servidor Público Estadual de São Paulo, Brazil. Electronic address: rafaelsoon@hotmail.com.
² Hospital do Servidor Público Estadual de São Paulo, Brazil.

Comment

Rafael de Athayde Soares et al. Surgery. 2020 Feb.

. 2020 Feb;167(2):515-516.

doi: 10.1016/j.surg.2019.08.004. Epub 2019 Oct 4.

¹ Hospital do Servidor Público Estadual de São Paulo, Brazil. Electronic address: rafaelsoon@hotmail.com.
² Hospital do Servidor Público Estadual de São Paulo, Brazil.

No abstract available

Comment on

Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin.
de Athayde Soares R, Matielo MF, Brochado Neto FC, Nogueira MP, Almeida RD, Sacilotto R. de Athayde Soares R, et al. Surgery. 2019 Dec;166(6):1076-1083. doi: 10.1016/j.surg.2019.05.030. Epub 2019 Jul 2. Surgery. 2019. PMID: 31277885 Clinical Trial.
On the questionable ethics of randomizing patients with acute DVT to receive rivaroxaban or warfarin.
Prandoni P. Prandoni P. Surgery. 2020 Feb;167(2):515. doi: 10.1016/j.surg.2019.07.005. Epub 2019 Aug 9. Surgery. 2020. PMID: 31405579 No abstract available.